Skip to content

A Study on the Efficacy Evaluation and Prediction of the "Harmonizing the Middle and Regulating the Mind" Method in Treating Functional Gastrointestinal Disorders with Anxiety and Depression Disorders in the Real World (1) Clinical Research on the "Harmonizing the Middle and Regulating the Mind" Method in Treating Functional Dyspepsia with Anxiety and Depression Disorders

A Study on the Efficacy Evaluation and Prediction of the "Harmonizing the Middle and Regulating the Mind" Method in Treating Functional Gastrointestinal Disorders with Anxiety and Depression Disorders in the Real World (1) Clinical Research on the "Harmonizing the Middle and Regulating the Mind" Method in Treating Functional Dyspepsia with Anxiety and Depression Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002298
Enrollment
Unknown
Registered
2025-11-21
Start date
2025-11-24
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia with anxiety and depression disorders

Interventions

Experimental group:Drug treatment: The experimental group was given the formula granules of Huanglian Wendan Decoction orally half an hour after breakfast and dinner for 4 consecutive weeks.
Control group:Drug treatment: The experimental group received a placebo containing 10% of the dosage of Huanglian Wendan Decoction, taken orally half an hour after breakfast and dinner for 4 consecuti

Sponsors

Shandong University of Traditional Chinese Medicine Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meeting the Western medical diagnostic criteria of FD and ADD as well as the TCM syndrome differentiation criteria; (2) Aged 18 to 65 years old; (3) No obvious organic diseases were found upon gastroscopy; (4) Voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the diagnostic criteria or have too many concurrent syndromes; (2) Those with HP infection; (3) Those with organic diseases causing dyspeptic symptoms, such as peptic ulcers, reflux esophagitis, bile reflux, erosive gastritis (grade 2 or above), atrophic gastritis (except for focal atrophy in the antrum), digestive tract tumors, etc.; those with pathological findings of gastric mucosa showing dysplasia, intestinal obstruction, liver, biliary and pancreatic diseases, etc.; (4) Those with systemic diseases that can cause digestive system symptoms, such as diabetes, renal insufficiency, connective tissue diseases, etc.; (5) Those with severe heart disease, liver cirrhosis, renal failure, malignant tumors and other life-threatening diseases; (6) Pregnant or lactating women; (7) Those with a history of alcohol or drug abuse; (8) Those who have participated in drug trials within the past 3 months; (9) Those currently taking medications that may affect the efficacy evaluation of the test drug (such as acid suppressants/antacids, non-steroidal anti-inflammatory drugs, anticholinergic drugs, glucocorticoids, antidepressants, etc.); (10) Those with a history of severe allergies or known allergies to the components of this drug; (11) Those with cognitive dysfunction, depression or other serious mental disorders; (12) Those with severe hearing or vision impairment, unable to complete the scale assessment.

Design outcomes

Primary

MeasureTime frame
Symptom score in Traditional Chinese Medicine;Self-Rating Anxiety Scale;Nepean Dyspepsia Index;Self-Rating Depression Scale;

Secondary

MeasureTime frame
Microbiome sequencing;Transcriptome sequencing;

Countries

China

Contacts

Public ContactXiaoyan Yan

Shandong University of Traditional Chinese Medicine Affiliated Hospital

13793188507@163.com+86 137 9318 8507

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026